FDA/NEI LASIK Safety Study is in the works.  The FDA and NEI have issued a request for proposals to identify five refractive surgery clinical sites throughout the United States to participate in a post-marketing clinical study to evaluate a questionnaire for measuring the level of patient satisfaction and visual symptoms at one and three months following LASIK surgery. Proposals are due May 25, by 5 p.m. EDT. Notification of selected sites is anticipated to occur this summer. The RFP may be completed online. This national, multi-center clinical trial is the last of a three-phase study called the LASIK Quality of Life Collaboration Project, launched on the heels of a public hearing held in April 2008 by the FDA’s Ophthalmic Devices Panel. The project is a government partnership among the FDA, the Department of Defense and NEI. Continue reading on the AAO Eye on Advocacy blog.